BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 12604808)

  • 1. Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1.
    Blomqvist S; Bruu AL; Stenvik M; Hovi T
    J Gen Virol; 2003 Mar; 84(Pt 3):573-580. PubMed ID: 12604808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete genomic characterization of an intertypic Sabin 3/Sabin 2 capsid recombinant.
    Dedepsidis E; Pliaka V; Kyriakopoulou Z; Brakoulias C; Levidiotou-Stefanou S; Pratti A; Mamuris Z; Markoulatos P
    FEMS Immunol Med Microbiol; 2008 Apr; 52(3):343-51. PubMed ID: 18328076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of a recombinant type 3/type 2 poliovirus with a chimeric capsid VP1 from sewage in Shandong, China.
    Tao Z; Wang H; Xu A; Zhang Y; Song L; Zhu S; Li Y; Yan D; Liu G; Yoshida H; Liu Y; Feng L; Chosa T; Xu W
    Virus Res; 2010 Jun; 150(1-2):56-60. PubMed ID: 20206214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak.
    Shaw J; Jorba J; Zhao K; Iber J; Chen Q; Adu F; Adeniji A; Bukbuk D; Baba M; Henderson E; Dybdahl-Sissoko N; McDonald S; Weldon WC; Gumede N; Oberste MS; Kew OM; Burns CC
    J Virol; 2018 May; 92(9):. PubMed ID: 29444940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a rare natural intertypic type 2/type 3 penta-recombinant vaccine-derived poliovirus isolated from a child with acute flaccid paralysis.
    Zhang Y; Wang H; Zhu S; Li Y; Song L; Liu Y; Liu G; Nishimura Y; Chen L; Yan D; Wang D; An H; Shimizu H; Xu A; Xu W
    J Gen Virol; 2010 Feb; 91(Pt 2):421-9. PubMed ID: 19846676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis.
    Martín J; Samoilovich E; Dunn G; Lackenby A; Feldman E; Heath A; Svirchevskaya E; Cooper G; Yermalovich M; Minor PD
    J Virol; 2002 Nov; 76(21):10921-8. PubMed ID: 12368335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare natural type 3/type 2 intertypic capsid recombinant vaccine-related poliovirus isolated from a case of acute flaccid paralysis in Brazil, 2015.
    Cassemiro KMSM; Burlandy FM; da Silva EE
    J Gen Virol; 2016 Jul; 97(7):1545-1550. PubMed ID: 27082658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis.
    Furione M; Guillot S; Otelea D; Balanant J; Candrea A; Crainic R
    Virology; 1993 Sep; 196(1):199-208. PubMed ID: 8102826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sabin type 2 polioviruses with intertypic vaccine/vaccine recombinant genomes.
    Georgopoulou A; Markoulatos P
    Eur J Clin Microbiol Infect Dis; 2001 Nov; 20(11):792-9. PubMed ID: 11783695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural type 3/type 2 intertypic vaccine-related poliovirus recombinants with the first crossover sites within the VP1 capsid coding region.
    Zhang Y; Zhu S; Yan D; Liu G; Bai R; Wang D; Chen L; Zhu H; An H; Kew O; Xu W
    PLoS One; 2010 Dec; 5(12):e15300. PubMed ID: 21203565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
    Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS
    J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.
    Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
    J Virol; 1988 Aug; 62(8):2828-35. PubMed ID: 2839704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of antigenic properties of vaccine derived poliovirus strains.
    Pliaka V; Achilleos C; Kyriakopoulou Z; Tsakogiannis D; Ruether IG; Gartzonica C; Levidiotou-Stefanou S; Markoulatos P
    Vaccine; 2010 Dec; 29(1):26-33. PubMed ID: 20974307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia.
    Blomqvist S; Savolainen C; Laine P; Hirttiö P; Lamminsalo E; Penttilä E; Jöks S; Roivainen M; Hovi T
    J Virol; 2004 May; 78(9):4876-83. PubMed ID: 15078968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent isolation of poliovirus 3 strains with chimeric capsid protein Vp1 suggests a recombination hot-spot site in Vp1.
    Blomqvist S; Savolainen-Kopra C; Paananen A; El Bassioni L; El Maamoon Nasr EM; Firstova L; Zamiatina N; Kutateladze T; Roivainen M
    Virus Res; 2010 Aug; 151(2):246-51. PubMed ID: 20493912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
    Korotkova EA; Gmyl AP; Yakovenko ML; Ivanova OE; Eremeeva TP; Kozlovskaya LI; Shakaryan AK; Lipskaya GY; Parshina IL; Loginovskikh NV; Morozova NS; Agol VI
    J Virol; 2016 Jul; 90(13):5978-88. PubMed ID: 27099315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 poliovirus recombinants isolated from vaccine-associated cases and from healthy contacts in Brazil.
    Friedrich F; Da-Silva EF; Schatzmayr HG
    Acta Virol; 1996 Feb; 40(1):27-33. PubMed ID: 8886095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine derived bi- and multi-recombinant Sabin strains.
    Paximadi E; Karakasiliotis I; Bolanaki E; Krikelis A; Markoulatos P
    Virus Genes; 2007 Dec; 35(3):541-8. PubMed ID: 17680217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term excretion of vaccine-derived poliovirus by a healthy child.
    Martín J; Odoom K; Tuite G; Dunn G; Hopewell N; Cooper G; Fitzharris C; Butler K; Hall WW; Minor PD
    J Virol; 2004 Dec; 78(24):13839-47. PubMed ID: 15564492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis.
    Buttinelli G; Donati V; Fiore S; Marturano J; Plebani A; Balestri P; Soresina AR; Vivarelli R; Delpeyroux F; Martin J; Fiore L
    J Gen Virol; 2003 May; 84(Pt 5):1215-1221. PubMed ID: 12692287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.